Health care systems that are plagued with problems involving data exchange interoperability may benefit from using cloud-based services. However, when it comes to actually using the cloud, the healthcare industry has a way to go. While financial industries have long relied on data flow to survive, the healthcare industry has not seemed to follow suit. In general, health care systems do not talk to each other.
Currently, the Center for Medical Interoperability is working to select a team of engineers to participate in creating an interoperability blueprint for health care networks. This blueprint could be used to certify health care products as being able to work in the cloud.
These findings were published by Health Data Management on May 10, 2016.
Dr. Brian Patty, the Chief Medical Informatics Officer from Rush University Medical Center, has recently shared his opinion on physician documentation reforms. Currently, the development of electronic health records systems is moving toward universalization, but Dr. Patty believes that the current system is over-burdening doctors. He believes that EHRs are often crowded with too much content and are poorly organized, and the result could be physician frustration and possible medical errors.
Dr. Patty has offered suggestions on what could be done to reduce this data burden. He believes that EHR designers need to create more templates to make it easier and faster to enter information. He also suggests that some of the data required for meaningful use reporting could be recorded by other care team members, thus reducing the amount of time that physicians need to spend on documentation.
These findings were published in Healthcare Informatics on April 15, 2016.
According to the National Safety Council, about 99% of physicians are currently prescribing opioids in longer durations than recommended by the Centers for Disease Control and Prevention. Many doctors say that they prescribe some form of opioid pain control even though evidence suggests that they are not the most effective medications for pain relief.
These findings came from a survey of over 200 physicians, the majority of which incorrectly believe that Oxycodone and Morphine are the most efficient pain relief options available. About two-thirds of physicians said their patients’ expectations had an impact on their decision to prescribe opioids, indicating that better education about these medications is needed among both patients and healthcare providers.
These findings were published in Risk & Insurance on April 18, 2016.
British researchers from the University of York have recently found that lonely people living in isolation could face a heightened risk of heart disease and stroke. These findings came from analyzing previously published studies that included over 180,000 adults. From this group, about 4,600 had heart attacks or angina and over 3,000 suffered strokes.
The data showed that social isolation and loneliness were associated with a 29% increased heart attack or angina attack risk, as well as a 32% increased stroke risk. These findings show that heart disease and stroke prevention efforts could significantly benefit from taking loneliness and isolation into account.
These results were published in Heart on April 19, 2016.
A recent study has found that insulin treatment is not responsible for the poorer health outcomes after stenting in patients with type 2 diabetes. However, it was suggested that everolimus-eluting stents might be a better choice for patients using insulin.
Researchers found that after adjusting for certain risks, insulin-treated type 2 diabetes patients who underwent stenting did not experience an increased rate of combined cardiac death, target vessel revascularization, or target vessel myocardial infarction when compared to patients taking other types of anti-diabetes medications.
The findings were based on the health outcomes of over 1,800 patients and suggested that the increased possibility of cardiovascular events among patients treated with insulin might actually be due to differences in baseline risk factors as well as disease control and duration.
These findings were published in JAMA Cardiology on April 20, 2016.
A recent study has found that small improvements in HbA1c in people with diabetes can reduce health complications and the economic costs associated with treating them. This research was completed in the UK and analyzed data from adults living with type 1 and type 2 diabetes. Findings showed that improved glycemic control could potentially lead to preventing one million microvascular complications. These included diabetic foot diseases, such as neuropathy, amputations, and foot ulcers.
The cost savings of improved glycemic control were also thought to be substantial. Cost reductions associated with avoiding diabetic complications over 25 years were projected to reach almost $8 billion.
These findings were published in Diabetic Medicine on April 15, 2016.
According to the National Academies of Sciences, Engineering, and Medicine, to provide health care for at-risk Medicare beneficiaries and populations, providers will need to hold themselves accountable for the care that they provide. Reducing health inequities requires organizations to accept responsibility for its health outcomes.
Researchers have outlined six ways that providers could improve health care for at-risk communities:
Commitment to health equality
Data and measurement
Comprehensive needs assessment
By following these steps and employing adequate resources, it is possible to deliver quality care to at-risk populations.
These findings were published in MedPage Today on April 12, 2016.
A study found in Obesity Reviews showed that phosphodiesterase 4 (PDE4) inhibition could be useful in the treatment of metabolic disorders. Researchers discovered that signaling disruptions between cyclic adenosine monophosphate and PDE4 represented a meaningful pathway for metabolic diseases.
A few PDE4 inhibitors are currently going through clinical evaluation to treat some metabolic disorders, including non-alcoholic steatohepatitis and type 2 diabetes. The discovery of PDE4 allosteric inhibitors along with strategies that target individual PDE4 variants could allow for PDE4 isoform selective inhibition. This could potentially offer safe strategies when it comes to the treatment of chronic metabolic disorders.
These findings were published in Obesity Reviews on March 21, 2016.
Researchers have found that pregnancy lipid profiles could identify women who are at risk for gestational diabetes. In women who developed the disease, a variety of conditions were noted, including lower HDL concentration, lower LDL peak diameter, and higher concentrations of small LDL particles.
Lipoprotein profiles that indicate these scenarios up to seven years before pregnancy are associated with an increased likelihood of gestational diabetes development. A causal mechanism for this relationship has not yet been identified. However, the findings are consistent with the possibility that an improvement in cardiometabolic risk profile in women of a reproductive age could reduce the risk of gestational diabetes.
This information was published in the Journal of Clinical Endocrinology & Metabolism on April 5, 2016.
A new study has found that the public is still split about the Affordable Care Act; however, a growing minority of people are starting to come around to the idea that the law is improving healthcare access. A majority of Americans still think that the law has had minimal impact on insurance coverage, assistance for medications for seniors, and access to healthcare. That majority is shrinking as more people are starting to appreciate the effects of the law.
The greatest change in opinion came from people who were insured in 2014 but did not have health insurance in 2010. This group was twice as likely as others to say that the Affordable Care Act had expanded health care access.
These findings were published in The Washington Post on April 13, 2016.